Daptomycin in the left-sided endocarditis: A single center experience

AÇAR B., Tekce Y. T., Yayla C., Unal S., Ertem A. G., ŞENTÜRK B., ...Daha Fazla

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.45, sa.4, ss.310-315, 2017 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 45 Sayı: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.5543/tkda.2017.60784
  • Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.310-315
  • Anahtar Kelimeler: Daptomycin, left sided infective endocarditis, S. aureu, HIGH-DOSE DAPTOMYCIN, INFECTIVE ENDOCARDITIS, STAPHYLOCOCCUS-AUREUS, THERAPY, MULTICENTER, BACTEREMIA, VANCOMYCIN, EFFICACY, SAFETY, DIAGNOSIS
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective: Infective endocarditis (IE) carries a high risk of cardiac morbidity and mortality, despite advances in the contemporary armamentarium. Along with the development of antibiotic resistant strains, research focusing on the efficacy of novel agents other than standard antibiotic regimens continues. Daptomycin, one of these antibiotics, is approved for the treatment of Staphylococcus bacteremia and right-sided endocarditis. This retrospective study was an investigation of the effectiveness of daptomycin in patients with left-sided IE.